Temadex 200 & 500 200mg & 500mg Solution for injection
PDF Leaflet Revision Date: 09 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Routine reversal of neuromuscular blockade induced by rocuronium or vecuronium.
Dosage (summary)
4 mg/kg for profound blockade, 2 mg/kg for shallow blockade, 16 mg/kg for immediate reversal.
Onset of Action / Duration
Onset: 3 mins, Duration: varies.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
- Obese patients
- Children > 7 years
Pregnancy & Breastfeeding
Safety in pregnancy not established; excretion in breast milk expected.
Key Drug Interactions
- Toremifene
- Fusidic acid
- Hormonal contraceptives
Contraindications
- Hypersensitivity to sugammadex
Common side effects
- Cough
- Dysgeusia
- Airway complications
- Procedural hypotension
Counselling Points
- Monitor for bradycardia post-administration.
- Ensure adequate ventilation until recovery.
- Inform about potential hypersensitivity reactions.
Serious warnings
- Marked bradycardia
- Risk of recurrence of neuromuscular blockade
- Not for use with depolarizing agents
Important Disclaimer
The Temadex 200 & 500 200mg & 500mg Solution for injection professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
